Metabolic changes following sibutramine-assisted weight loss in obese individuals: Role of plasma free fatty acids in the insulin resistance of obesity

Metabolism: Clinical and Experimental

Volumn 50, Issue 7, 2001, Pages 819-824

  McLaughlin, T ^a   Abbasi, F ^a   Lamendola, C ^a   Kim, H S ^a   Reaven, G M ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; GLUCOSE; INSULIN; OCTREOTIDE; SIBUTRAMINE;

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONCENTRATION (PARAMETERS); CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET RESTRICTION; DISEASE ASSOCIATION; DISEASE COURSE; DRUG EFFECT; FATTY ACID BLOOD LEVEL; FEEDING BEHAVIOR; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; METABOLIC PARAMETERS; OBESITY; POPULATION RISK; PRIORITY JOURNAL; REGULATORY MECHANISM; STEADY STATE; TREATMENT OUTCOME; VOLUNTEER; WEIGHT REDUCTION;

EID: 0034926963     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1053/meta.2001.24220     Document Type: Article

References (28)

1. Forearm metabolism in obesity and its response to intra-arterial insulin
2. Effects of weight reduction on obesity: Studies of carbohydrate and lipid metabolism
3. Mechanisms of insulin resistance in human obesity. Evidence for receptor and postreceptor defects
4. Effect of obesity on ambient plasma glucose free fatty acid, insulin, growth hormone, and glucagon concentrations
5. The glucose-fatty acid cycle: Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus
6. Effect of long-chain triglyceride infusion on glucose metabolism in man
7. Effect of fatty acids on glucose production and utilization in man
8. Operation of Randle's cycle in patients with NIDDM
9. Insulin resistance and hypersecretion in obesity
10. Roles of insulin resistance and obesity in regulation of plasma insulin concentrations
11. Differences in insulin resistance do not predict weight loss in response to hypocaloric diets in healthy obese women
12. Report of the expert committee on the diagnosis and classification of diabetes mellitus
13. Evaluation of octreotide to assess insulin-mediated glucose disposal by the insulin suppression test
14. Comparison of impedence to insulin-mediated glucose uptake in normal subjects and in subjects with latent diabetes
15. A new and rapid method for determination of glucose by measurement of rate of oxygen consumption
16. Immunoassay of insulin with insulin-antibody precipitate
17. Relationship between several surrogate estimates of insulin resistance and quantification of insulin-mediated glucose disposal in 490 healthy nondiabetic volunteers
18. A new calorimetric microdetermination of free fatty acids in serum
19. Regulation of non-esterified fatty acid and glycerol concentration by insulin in normal individuals and patients with type 2 diabetes
20. Relationship between insulin-mediated glucose disposal by muscle and adipose tissue lipolysis in healthy volunteers
21. Insulin regulation of plasma free fatty acid concentrations is abnormal in healty subjects with muscle insulin resistance
22. Insulin suppression of plasma-free fatty acid concentration in normal individuals and patients with type 2 (non-insulin-dependent) diabetes
23. Non-esterified fatty acids and the liver: Why is insulin secreted into the portal vein
24. Fatty acids in the portal vein of the rat regulate hepatic insulin clearance
25. Free fatty acids impair hepatic insulin extractions in vivo
26. Sibutramine procludes dose-related weight loss
27. Changes in plasma lipids and lipoproteins in overweight men during weight loss through dieting as compared with exercise